ENTA as of Oct 30 · 23:54 ET
ENTANasdaqPharmaceutical Preparations

Enanta Pharmaceuticals Inc · Brief

Next report

16 days

Nov 16 · after closeest.Q4 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±17.0%
avg realized
±5.6%
Nov 25 '24±12.3%▼−4.99%×0.40
Feb 10 '25±20.3%▲+14.08%×0.69
May 12 '25±14.5%▼−5.77%×0.40
Aug 11 '25±20.5%▲+5.70%×0.28
Nov 17 '25±17.1%▼−3.59%×0.21
Q1 FY26±13.1%▲+2.17%×0.17
Q2 FY26±19.0%▼−6.02%×0.32
Q3 FY26±19.1%▼−2.10%×0.11
quarterimplied−25%0+25%realized×
Q3 FY26±19.1%▼−2.10%×0.11
Q2 FY26±19.0%▼−6.02%×0.32
Q1 FY26±13.1%▲+2.17%×0.17
Nov '25±17.1%▼−3.59%×0.21
Aug '25±20.5%▲+5.70%×0.28
May '25±14.5%▼−5.77%×0.40
2 older reports
Feb '25±20.3%▲+14.08%×0.69
Nov '24±12.3%▼−4.99%×0.40
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 16 report · est.

Bull2

121managers reporting positions in the latest quarterly filings13F · Jun 30 '26
+8.76%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
14managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ENTA report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.